http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104558109-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08 |
| filingDate | 2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104558109-B |
| titleOfInvention | Derived from polypeptide compound of the rape pollen with ACE inhibitory activity and application |
| abstract | Inhibit Angiotensin-Converting derived from having for rape pollen the present invention relates to a kind of（angiotensin‑converting enzyme,ACE）The polypeptide compound LAVNLIPFP of activity, amino acid sequence is respectively Leu Ala Val Asn Leu IIe Pro Phe Pro.Polypeptide LAVNLIPFP has ACE inhibitory activity, and health products and lead compound as hypertension, heart disease and cardiovascular disease have a good application prospect. |
| priorityDate | 2013-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.